Clinical Lipidomics Unit

The Lipidomics facility aims to investigate the dynamics of membrane lipids and bioactive lipids in neurobiological processes using state-of-the-art mass spectrometry techniques. The discovery of lipid signatures of various physiological and/or pathophysiological states, as well as the translation of neurobiological knowledge into quantitative assays for monitoring of changes in the endogenous levels of lipids and bioactive lipids in various tissues and bodily fluids associated with different neuropsychiatric and neurodegenerative diseases, represent the main research activities of the unit.

Fig. 2: Schematic representation of the quantification workflow of endocannabinoids and related lipids.

The Lipidomics unit collaborates closely with researchers within University Medical Center Mainz, FTN and Institute for Molecular Biology in Mainz, as well as with regional and international medical and academia centers.

The group serves also as a core resource facility of the FTN platform LiPiD, providing quantitative determination of endocannabinoids and other bioactive lipids on a fee-for-service basis. The unit is equipped with modern quantitative mass spectrometer, liquid chromatography systems, high-throughput sample preparation tools, lipidomic software solutions, etc.

For information on collaboration, requests for measurements and internship application please contact Dr. Laura Bindila ( email, Fon: +49 6131 39 25794).

Further Information about the Research Group